- Home
- AVR vs SEVN Comparison
AVR vs SEVN Comparison
Compare AVR & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- SEVN
- Stock Information
- Founded
- AVR 1999
- SEVN 1986
- Country
- AVR Australia
- SEVN United States
- Employees
- AVR N/A
- SEVN N/A
- Industry
- AVR
- SEVN Real Estate Investment Trusts
- Sector
- AVR
- SEVN Real Estate
- Exchange
- AVR NYSE
- SEVN Nasdaq
- Market Cap
- AVR 162.1M
- SEVN 179.3M
- IPO Year
- AVR 2024
- SEVN N/A
- Fundamental
- Price
- AVR $3.33
- SEVN $10.26
- Analyst Decision
- AVR Strong Buy
- SEVN Strong Buy
- Analyst Count
- AVR 4
- SEVN 3
- Target Price
- AVR $16.50
- SEVN $13.50
- AVG Volume (30 Days)
- AVR 202.3K
- SEVN 87.3K
- Earning Date
- AVR 08-16-2025
- SEVN 07-28-2025
- Dividend Yield
- AVR N/A
- SEVN 10.86%
- EPS Growth
- AVR N/A
- SEVN N/A
- EPS
- AVR N/A
- SEVN 1.04
- Revenue
- AVR $2,493,000.00
- SEVN $29,272,000.00
- Revenue This Year
- AVR $33.26
- SEVN $7.45
- Revenue Next Year
- AVR $194.42
- SEVN $1.12
- P/E Ratio
- AVR N/A
- SEVN $9.89
- Revenue Growth
- AVR N/A
- SEVN N/A
- 52 Week Low
- AVR $2.34
- SEVN $10.18
- 52 Week High
- AVR $8.79
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- SEVN 29.62
- Support Level
- AVR N/A
- SEVN $10.57
- Resistance Level
- AVR N/A
- SEVN $10.87
- Average True Range (ATR)
- AVR 0.00
- SEVN 0.28
- MACD
- AVR 0.00
- SEVN -0.09
- Stochastic Oscillator
- AVR 0.00
- SEVN 1.26
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.